Exercise program for people with Fabry disease
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests a structured exercise program designed to improve fitness in people with Fabry disease. It aims to see whether regular exercise is a safe and helpful way to support your health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of Fabry disease.
- You must be at least 18 years old.
- You must be under the care of a participating study center.
- Your health must be stable enough for exercise testing and training, as approved by a doctor.
- You must be able to understand the study and give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if enzyme replacement therapy works well and is safe for Fabry disease. It is for people who are already prescribed this treatment.
This study is looking at how to improve the care and follow-up for people with Fabry's disease, a rare genetic disorder. It aims to create a better care pathway to help patients manage their condition.
This trial tests whether agalsidase alfa can reduce heart inflammation in people with Fabry disease who have heart problems. You may qualify if you have not had this treatment in the past year.
This study tests an enzyme replacement therapy (agalsidase alfa) for Fabry disease in Chinese children and adults. It's an observational study that follows patients who receive the treatment as part of their regular care.
This study looks at how the heart is affected in adults with Fabry disease. It may help doctors better understand heart-related changes in order to guide care.
This study checks whether certain heart-related blood tests and heart scans can help monitor people with Fabry disease. It may be useful for both people who have never received enzyme replacement therapy and those who have.
Hear when a new Fabry Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.